This is a review about APP, based on 54 published articles (read how Labome selects the articles), using APP antibody in all methods. It is aimed to help Labome visitors find the most suited APP antibody.
APP synonym: AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2; alzheimer disease amyloid protein; amyloid beta A4 protein; beta-amyloid peptide; cerebral vascular amyloid peptide; peptidase nexin-II; preA4; protease nexin-II

gallery
EMD MilliporeEMD Millipore APP product
  • immunocytochemistryIn 2005, Zoia Muresan et al. applied EMD Millipore APP antibody to study the coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1 [ncbi , more ]. In 2004, Zoia Muresan et al. used EMD Millipore APP antibody to detect APP in CAD cells with APP transfection (catalog: AB5352) [ncbi , more ]. In 2003, Yuzhi Chen et al. employed EMD Millipore APP antibody to study the effect of APP-BP1 on APP-induced apoptosis and DNA synthesis in Alzheimer's disease brain [ncbi , more ].
  • immunohistochemistryGabor G Kovacs et al. used EMD Millipore APP antibody to elucidated the role of white matter tauopathy in frontotemporal lobar degeneration [ncbi , more ] in 2008 and Michael R Dorwart et al. used EMD Millipore APP antibody to perform immunofluorescence in order to investigate the molecular mechanism by which four CLD-causing mutations in the STAS domain lead to disease [ncbi , more ]. Zoia Muresan et al. applied EMD Millipore APP antibody to study the coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1 [ncbi , more ] in 2005 and Sandra Grau et al. used EMD Millipore APP antibody to perform immunohistochemistry in order to study the role of serine protease HtrA1 in amyloid precursor protein processing (catalog: MAB5206) [ncbi , more ].
  • immunoprecipitationShuji Matsuda et al. used EMD Millipore APP antibody to investigate the binding of the BRI2 to APP precursor protein [ncbi , more ] in 2005 and Yoshifumi Nakaya et al. used EMD Millipore APP antibody to study the biological function of presenilin-1 maturation [ncbi , more ].
  • western blotIn 2009, Matthew L Hemming et al. used EMD Millipore APP antibody to perform western blot in order to show that new BACE1 substrates were identified by quantitative proteomics [ncbi , more , fig ]. In 2008, Carmela Matrone et al. utilized EMD Millipore APP antibody to study the role of NGF or BDNF signaling in neuronal apoptotic death [ncbi , more ]. In 2006, Mikko Hiltunen et al. utilized EMD Millipore APP antibody to study the role for ubiquilin 1 in modulating amyloid precursor protein trafficking and Abeta secretion [ncbi , more ]. EMD Millipore APP antibody was employed in 2005 to detect APP in CHO-APP695 Cells (catalog: MAB348) [ncbi , more ], to study the biological function of presenilin-1 maturation [ncbi , more ], to study Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death [ncbi , more ]and to investigate the binding of the BRI2 to APP precursor protein [ncbi , more ]. Hiroshi Hasegawa et al. used EMD Millipore APP antibody to study intermolecular interactions and function of presenilin complexes [ncbi , more ] in 2004 and Zoia Muresan et al. used EMD Millipore APP antibody to detect APP in CAD cells with APP transfection (catalog: AB5352) [ncbi , more ]. EMD Millipore APP antibody was employed in 2003 to study the linking of amyloid protein precursor to the kinesin light chain through the scaffold protein JNK-interacting protein 1 [ncbi , more ], to study the function of presenilin 1 mutations in kinesin-based axonal transport [ncbi , more ]and to detect AbetaPP in HEK 293 cells transfected with various combinations of JIP-1, JNK, and MLK3 [ncbi , more ].
Life Technologies CorporationLife Technologies Corporation APP product
  • ELISAIn 2004, Yung Feng Liao et al. applied Life Technologies Corporation APP antibody to study amyloid precursor protein cleavage through a JNK-dependent MAPK pathway [ncbi , more ].
  • immunocytochemistryIn 2004, Zoia Muresan et al. utilized Life Technologies Corporation APP antibody to detect APP in CAD cells to further characterize the nature of the speckle-associated pAPP antigen [ncbi , more ].
  • immunoprecipitationIn 2010, Stephanie J Soscia et al. employed Life Technologies Corporation APP antibody to perform immunoprecipitation in order to clarify that amyloid beta is an antimicrobial peptide that may normally function in the innate immune system [ncbi , more ]. Zoia Muresan et al. applied Life Technologies Corporation APP antibody to study the coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1 [ncbi , more ] in 2005 and Shuji Matsuda et al. used Life Technologies Corporation APP antibody to investigate the binding of BRI2 to APP precursor protein [ncbi , more ]. In 2003, Meir H Scheinfeld et al. utilized Life Technologies Corporation APP antibody to detect AbetaPP in HEK 293 cells transfected with various combinations of JIP-1, JNK, and MLK3 [ncbi , more ].
  • western blotIn 2008, Rafael Mattera et al. employed Life Technologies Corporation APP antibody to demonstrate that cycles of Ub binding and monoubiquitination regulate the association of Rabex-5 with endosomes [ncbi , more ]. In 2005, Shuji Matsuda et al. used Life Technologies Corporation APP antibody to investigate the binding of BRI2 to APP precursor protein [ncbi , more ]. Meir H Scheinfeld et al. utilized Life Technologies Corporation APP antibody to detect AbetaPP in HEK 293 cells transfected with various combinations of JIP-1, JNK, and MLK3 [ncbi , more ] in 2003 and Davide Gianni et al. used Life Technologies Corporation APP antibody to study the pathway for platelet-derived growth factor to induce the beta-gamma-secretase-mediated cleavage of alzheimer's amyloid precursor protein [ncbi , more ].
Cell Signaling TechnologyCell Signaling Technology APP product
  • immunocytochemistryIn 2004, Zoia Muresan et al. employed Cell Signaling Technology APP antibody to detect phospho-APP in CAD cells and mouse cortical neurons, COS-1, MDCK, and bovine aortic endothelial (BAEC) cells [ncbi , more ].
  • western blotIn 2005, Zoia Muresan et al. applied Cell Signaling Technology APP antibody to study the coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1 [ncbi , more ]. In 2004, Zoia Muresan et al. employed Cell Signaling Technology APP antibody to detect phospho-APP in CAD cells and mouse cortical neurons, COS-1, MDCK, and bovine aortic endothelial (BAEC) cells [ncbi , more ].
EpitomicsEpitomics APP product
  • immunohistochemistryIn 2009, Zilai Wang et al. utilized Epitomics APP antibody to perform immunohistochemistry and western blot in order to study the roles of the amyloid precursor protein in peripheral and central synaptogenesis. [ncbi , more ].
  • western blotIn 2009, Zilai Wang et al. utilized Epitomics APP antibody to perform immunohistochemistry and western blot in order to study the roles of the amyloid precursor protein in peripheral and central synaptogenesis. [ncbi , more ].
Hycult Biotech
  • immunohistochemistryIn 2010, Stephanie J Soscia et al. applied Hycult Biotech APP antibody to perform western blot and immunoprecipitation in order to clarify that amyloid beta is an antimicrobial peptide that may normally function in the innate immune system [ncbi , more ].
  • western blotIn 2010, Stephanie J Soscia et al. applied Hycult Biotech APP antibody to perform western blot and immunoprecipitation in order to clarify that amyloid beta is an antimicrobial peptide that may normally function in the innate immune system [ncbi , more ].
Sigma-AldrichSigma-Aldrich APP product
  • immunohistochemistryIn 2007, Jacques Boddaert et al. utilized Sigma-Aldrich APP antibody to study the role for lactadherin in Alzheimer s disease in sections from human [ncbi , more ]. In 2006, Dietrich E Lorke et al. applied Sigma-Aldrich APP antibody to study the expression of serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients [ncbi , more ]. In 2005, Brent L Kelly et al. applied Sigma-Aldrich APP antibody to investigate the molecular mechanism of beta-amyloid induced significant decrease of dynamin1 [ncbi , more ].
  • immunoprecipitationIn 2006, Mikko Hiltunen et al. utilized Sigma-Aldrich APP antibody to study the role for ubiquilin 1 in modulating amyloid precursor protein trafficking and Abeta secretion [ncbi , more ].
  • western blotIn 2007, Cristina Caballero et al. applied Sigma-Aldrich APP antibody to detect the early phenotypic modifications of Alzheimer's disease (AD) models [ncbi , more ]. In 2006, Mikko Hiltunen et al. utilized Sigma-Aldrich APP antibody to study the role for ubiquilin 1 in modulating amyloid precursor protein trafficking and Abeta secretion [ncbi , more ]. In 2005, Akio Sumioka et al. used Sigma-Aldrich APP antibody to study the interaction of AICD with FE65 and 14-3-3 modulate FE65-dependent gene transactivation [ncbi , more ]. In 2004, Hiroshi Hasegawa et al. used Sigma-Aldrich APP antibody to study intermolecular interactions and function of presenilin complexes [ncbi , more ]. In 2003, Davide Gianni et al. used Sigma-Aldrich APP antibody to study the pathway for platelet-derived growth factor to induce the beta-gamma-secretase-mediated cleavage of alzheimer's amyloid precursor protein [ncbi , more ]. In 2002, Fusheng Chen et al. used Sigma-Aldrich APP antibody to study the effect of presenilin 1 mutations on gamma42-secretase and epsilon-secretase cleavage of amyloid precursor protein (APP) and s3-cleavage of notch [ncbi , more ].
DakoDako APP product
  • immunohistochemistryIn 2003, Cristina Benito et al. utilized Dako APP antibody to study the selective overexpression of cannabinoid CB2 receptors and fatty acid amide hydrolase in neuritic plaque-associated glia in alzheimers disease brains [ncbi , more ].
  • western blotIn 2001, W H Yu et al. employed Dako APP antibody to identify and analyze the S100 beta binding proteins [ncbi , more ].
ELAN PHARMACEUTICALS
  • immunocytochemistryIn 2005, Stephen T Brown et al. applied APP antibody to study hypoxic augmentation of Ca2+ channel currents [ncbi , more ].
  • immunohistochemistryIn 2004, Martin Ingelsson et al. used APP antibody to study the association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease [ncbi , more ].
AGRISERA AB
  • ELISAIn 2011, Sebastian Treusch et al. utilized APP antibody to perform ELISA in order to show that yeast could be used to model Abeta toxicity for potential modifier screen [ncbi , more ].
SYNETEK
  • western blotIn 2001, R Yan et al. utilized APP antibody to study BACE2 functions as an alternative alpha-secretase in cells [ncbi , more ].
SIGNET LABS
  • immunohistochemistryIn 2007, J B Leverenz et al. employed APP antibody to study a novel progranulin mutation associated with variable clinical presentation and tau, TDP43, and alpha-synuclein pathology [ncbi , more ].
EVOTEC
  • ELISAIn 2002, M Hasan Mohajeri et al. utilized APP antibody to study Abeta 42-induced neprilysin increase [ncbi , more ].
  • immunohistochemistryIn 2002, M Hasan Mohajeri et al. utilized APP antibody to study Abeta 42-induced neprilysin increase [ncbi , more ].
Covance
  • block or activateIn 2008, Carmela Matrone et al. utilized Covance APP antibody to study the role of NGF or BDNF signaling in neuronal apoptotic death [ncbi , more ].
  • immunocytochemistryIn 2005, Zoia Muresan et al. applied Covance APP antibody to study the coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1 [ncbi , more ].
  • immunohistochemistryIn 2010, Stephanie J Soscia et al. utilized Covance APP antibody to perform immunohistochemistry and western blot in order to clarify that Amyloid beta is an antimicrobial peptide that may normally function in the innate immune system [ncbi , more ]. In 2007, Nathalie Brouwers et al. applied Covance APP antibody to study whether PGRN genetic variability contributed to other common neurodegenerative brain diseases, such as Alzheimer disease (AD) or Parkinson disease (PD) in sections from human [ncbi , more ]. In 2006, James E Galvin et al. applied Covance APP antibody to study the muscle protein dysferlin accumulates in the Alzheimer brain [ncbi , more ]. In 2005, Zoia Muresan et al. applied Covance APP antibody to study the coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1 [ncbi , more ]. In 2002, Kelly T Dineley et al. employed Covance APP antibody to study the characterization of transgenic mouse lines co-expressing mutant human presenilin 1 and amyloid precursor proteins [ncbi , more ].
  • immunoprecipitationIn 2009, Kazuchika Nishitsuji et al. applied Covance APP antibody to study the effect of E693deletemutation in amyloid precursor protein on intracellular accumulation of amyloid beta oligomers and its role in causing endoplasmic reticulum stress-induced apoptosis in cultured cells [ncbi , more ]. Shuji Matsuda et al. used Covance APP antibody to investigate the binding of the BRI2 to APP precursor protein [ncbi , more ] in 2005 and Yoshifumi Nakaya et al. used Covance APP antibody to study the biological function of presenilin-1 maturation [ncbi , more ]. In 2001, E M Kajkowski et al. utilized Covance APP antibody to isolate amyloid-beta peptide in vitro [ncbi , more ].
  • western blotIn 2011, Sebastian Treusch et al. applied Covance APP antibody to perform western blot in order to show that yeast could be used to model Abeta toxicity for potential modifier screen [ncbi , more ]. In 2009, Martin C Herzig et al. utilized Covance APP antibody to detect APP in western blot in order to find out the different regulation of E22Q-mutant A beta peptide towards vascular amyloid and parenchymal A beta deposition [ncbi , more ]. In 2006, Mikko Hiltunen et al. utilized Covance APP antibody to study the role for ubiquilin 1 in modulating amyloid precursor protein trafficking and Abeta secretion [ncbi , more ]. Covance APP antibody was applied in 2005 to study the reduced secretion of APP and Abeta through the inhibition of glycosphingolipid biosynthesis [ncbi , more ], to study the effect of P2Y2 nucleotide receptors on alpha-secretase-dependent amyloid precursor protein processing [ncbi , more ], to study the biological function of Gamma-secretase [ncbi , more ]and to investigate the binding of the BRI2 to APP precursor protein [ncbi , more ]. Hiroshi Hasegawa et al. used Covance APP antibody to study intermolecular interactions and function of presenilin complexes [ncbi , more ] in 2004 and Keiro Shirotani et al. used Covance APP antibody to study distinct gamma-secretase complexes composed of the known subunits in human cells [ncbi , more ]. In 2003, Judianne Davis et al. applied Covance APP antibody to study the effect of pathogenic Abeta deposition on the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells [ncbi , more ]. Covance APP antibody was applied in 2002 to study a novel mechanism for the regulation of amyloid precursor protein metabolism [ncbi , more ], to study the enhancement of presenilin-mediated generation of amyloid beta-protein by the endoplasmic reticulum stress-inducible protein, Herp [ncbi , more ], to study the effect of alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor on Abeta secretion in human brain homogenates [ncbi , more ]and to study the characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms produced by alternative splicing of the RNA [ncbi , more ].
Boehringer Mannheim
  • immunocytochemistryIn 2001, B Kornek et al. used Boehringer Mannheim APP antibody to study the distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis [ncbi , more ].
  • immunohistochemistryIn 2001, B Kornek et al. used Boehringer Mannheim APP antibody to study the distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis [ncbi , more ].
biocat
  • immunohistochemistryIn 2009, Thomas Walther et al. applied biocat APP antibody to perform immunohistochemistry in order to show that the existence of peptides targeted by NEP can improve learning and memory in aged mice [ncbi , more ].
Roche Applied Science
  • western blotIn 2004, Steffen Rossner et al. employed Roche Applied Science APP antibody to study the role of Munc13-1 in regulation of secretory APP metabolism [ncbi , more ]. In 2002, Qi Chen et al. used Roche Applied Science APP antibody to study a novel mechanism for the regulation of amyloid precursor protein metabolism [ncbi , more ]. In 2001, R Yan et al. utilized Roche Applied Science APP antibody to study BACE2 functions as an alternative alpha-secretase in cells [ncbi , more ].
Figure
Chemicon anti-APP was used in 1:1,000 dilution to perform western blot in order to show that new BACE1 substrates were identified by quantitative proteomics.
APP antibody western blot EMD Millipore
Cell lysates were probed for the presence of myc-tagged BACE1 (top panel); endogenous full-length APP, which is present in a mature, fully glycosylated form (mAPP) and an incompletely glycosylated immature form (iAPP, middle panel); and membrane-boun
Matthew L Hemming et al. (2009). "Identification of beta-secretase (BACE1) substrates using quantitative proteomics".PMID 20041192
Articles Reviewed
  1. Sebastian Treusch et al. (2011). "Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast".PMID 22033521
  2. Stephanie J Soscia et al. (2010). "The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide".PMID 20209079
  3. Matthew L Hemming et al. (2009). "Identification of beta-secretase (BACE1) substrates using quantitative proteomics".PMID 20041192
  4. Zilai Wang et al. (2009). "Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis".PMID 19726636
  5. Thomas Walther et al. (2009). "Improved learning and memory in aged mice deficient in amyloid beta-degrading neutral endopeptidase".PMID 19240795
  6. Martin C Herzig et al. (2009). "E22Q-mutant Abeta peptide (AbetaDutch) increases vascular but reduces parenchymal Abeta deposition".PMID 19218342
  7. Kazuchika Nishitsuji et al. (2009). "The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells".PMID 19164507
  8. Gabor G Kovacs et al. (2008). "White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration".PMID 18800011
  9. Rafael Mattera et al. (2008). "Ubiquitin binding and conjugation regulate the recruitment of Rabex-5 to early endosomes".PMID 18772883
  10. Carmela Matrone et al. (2008). "NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons".PMID 18728191
  11. Michael R Dorwart et al. (2008). "Congenital chloride-losing diarrhea causing mutations in the STAS domain result in misfolding and mistrafficking of SLC26A3".PMID 18216024
  12. Nathalie Brouwers et al. (2007). "Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family".PMID 17923627
  13. J B Leverenz et al. (2007). "A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology".PMID 17439980
  14. Jacques Boddaert et al. (2007). "Evidence of a role for lactadherin in Alzheimer's disease".PMID 17322377
  15. Cristina Caballero et al. (2007). "Inter-individual variability in the expression of the mutated form of hPS1M146L determined the production of Abeta peptides in the PS1xAPP transgenic mice".PMID 17243176
  16. James E Galvin et al. (2006). "The muscle protein dysferlin accumulates in the Alzheimer brain".PMID 17024495
  17. Mikko Hiltunen et al. (2006). "Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion".PMID 16945923
  18. Dietrich E Lorke et al. (2006). "Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients".PMID 16640790
  19. Zoia Muresan et al. (2005). "Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1".PMID 16301330
  20. Akio Sumioka et al. (2005). "Role of 14-3-3gamma in FE65-dependent gene transactivation mediated by the amyloid beta-protein precursor cytoplasmic fragment".PMID 16223726
  21. Brent L Kelly et al. (2005). "Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease".PMID 16002400
  22. Shuji Matsuda et al. (2005). "The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production".PMID 15983050
  23. Irfan Y Tamboli et al. (2005). "Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide".PMID 15923191
  24. Shuxia Zhou et al. (2005). "CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production".PMID 15890777
  25. Sandra Grau et al. (2005). "Implications of the serine protease HtrA1 in amyloid precursor protein processing".PMID 15855271
  26. Stephen T Brown et al. (2005). "Hypoxic augmentation of Ca2+ channel currents requires a functional electron transport chain".PMID 15824110
  27. Jean M Camden et al. (2005). "P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing".PMID 15778502
  28. Yoshifumi Nakaya et al. (2005). "Random mutagenesis of presenilin-1 identifies novel mutants exclusively generating long amyloid beta-peptides".PMID 15764596
  29. Kohsuke Kanekura et al. (2005). "A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death".PMID 15579468
  30. Jay H Chyung et al. (2005). "Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage".PMID 15569674
  31. Yung Feng Liao et al. (2004). "Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway".PMID 15347683
  32. Martin Ingelsson et al. (2004). "Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease".PMID 15331159
  33. Hiroshi Hasegawa et al. (2004). "Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes".PMID 15322109
  34. Keiro Shirotani et al. (2004). "Identification of distinct gamma-secretase complexes with different APH-1 variants".PMID 15286082
  35. Steffen Rossner et al. (2004). "Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing".PMID 15123597
  36. Zoia Muresan et al. (2004). "A phosphorylated, carboxy-terminal fragment of beta-amyloid precursor protein localizes to the splicing factor compartment".PMID 14722157
  37. Cristina Benito et al. (2003). "Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains".PMID 14657172
  38. Yuzhi Chen et al. (2003). "APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain".PMID 14557245
  39. Meir H Scheinfeld et al. (2003). "Amyloid beta protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1".PMID 12917434
  40. Shuji Matsuda et al. (2003). "Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1".PMID 12893827
  41. Gustavo Pigino et al. (2003). "Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport".PMID 12805290
  42. Judianne Davis et al. (2003). "Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells".PMID 12754271
  43. Davide Gianni et al. (2003). "Platelet-derived growth factor induces the beta-gamma-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway".PMID 12645527
  44. Hiroshi Tanahashi et al. (2002). "Characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms lacking phosphotyrosine-interaction domains".PMID 12153398
  45. Fusheng Chen et al. (2002). "Presenilin 1 mutations activate gamma 42-secretase but reciprocally inhibit epsilon-secretase cleavage of amyloid precursor protein (APP) and S3-cleavage of notch".PMID 12119298
  46. M Hasan Mohajeri et al. (2002). "Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo".PMID 12105192
  47. Qi Chen et al. (2002). "A novel mechanism for the regulation of amyloid precursor protein metabolism".PMID 12093789
  48. Kelly T Dineley et al. (2002). "Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins".PMID 11912199
  49. Xiaorei Sai et al. (2002). "Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein".PMID 11799129
  50. Paul M Mathews et al. (2002). "Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: role for altered lysosomal hydrolase distribution in beta-amyloidogenesis".PMID 11551970
  51. R Yan et al. (2001). "BACE2 functions as an alternative alpha-secretase in cells".PMID 11423558
  52. B Kornek et al. (2001). "Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis".PMID 11353727
  53. E M Kajkowski et al. (2001). "beta -Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module".PMID 11278849
  54. W H Yu et al. (2001). "S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease".PMID 11264299